Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03168958 · ClinicalTrials.gov registry record · Phase 4
Methadone and Quality of Postoperative Recovery
A Phase 4 study of Quality of Recovery Scores, sponsored by Endeavor Health.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT03168958 is a Phase 4 study of Quality of Recovery Scores that is actively recruiting participants, run by Endeavor Health. The registered enrollment target is 130 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03168958, a Phase 4 study of Quality of Recovery Scores, is actively recruiting participants, sponsored by Endeavor Health.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients undergoing cardiac surgery often experience moderate to severe pain in the early postoperative period. A number of methods have been used to help control pain after surgery; however, each of these techniques adds additional costs and risks. A simple and effective way to decrease this pain is to administer a long-acting opioid in the operating room. Methadone is a opioid that can produce analgesia (pain relief) that lasts up to 48 hours when given in large doses (0.3 to 0.4 mg/kg). Previous studies have demonstrated that both pain and requirements for analgesic medications are significantly reduced for up to three days after surgery if methadone is given at induction (the start) of anesthesia. In the study that was performed at Evanston Hospital, cardiac surgical patients who were given methadone also appeared to "feel better" after surgery compared to those given a standard or typical intraoperative opioid. The aim of this randomized clinical trial is to determine whether overall quality of postoperative recovery can be enhanced if methadone is given in the operating room. Quality of recovery will be determined by using a validated scoring system, the QoR 40, which will be given to patients to complete on the first three days after surgery.
Conditions Studied
Interventions
- DRUG Methadone
- DRUG Saline
Study Locations (1)
Illinois
- NorthShore University HealthSystem - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2018-12-25 |
| Est. Completion | 2021-07-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03168958
The ClinicalTrials.gov registry entry for NCT03168958 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Quality of Recovery Scores appearing as the primary indexed condition, and to 2 interventions - of which Methadone is the first listed.
NCT03168958 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT03168958 about?
NCT03168958 is a clinical study titled "Methadone and Quality of Postoperative Recovery". Patients undergoing cardiac surgery often experience moderate to severe pain in the early postoperative period. A number of methods have been used to help control pain after surgery; however, each of these techniques adds additional costs and risks. A simple and effective way to decrease this pain i...
What is the current status of trial NCT03168958?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 130 participants. The study started on 2018-12-25. Estimated completion is 2021-07-25.
What conditions does trial NCT03168958 study?
This clinical trial studies the following conditions: Quality of Recovery Scores.
What interventions are being tested in trial NCT03168958?
The interventions under investigation include: Methadone (DRUG), Saline (DRUG).
Who is sponsoring clinical trial NCT03168958?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03168958 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.